Hugel, Inc. (KOSDAQ:145020)

South Korea · Delayed Price · Currency is KRW

252,500

-10,500 (-3.99%)

Apr 30, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	425.11B	373.05B	319.70B	281.68B	231.86B
Pharmaceuticals Growth	13.96%	16.69%	13.50%	21.49%	9.87%
Total	425.11B	373.05B	319.70B	281.68B	231.86B
Total Growth	13.96%	16.69%	13.50%	21.49%	9.87%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Korea	148.89B	147.81B	142.73B	131.27B	113.49B
Korea Growth	0.73%	3.56%	8.73%	15.67%	-6.59%
Asia	128.58B	118.63B	91.50B	83.00B	81.13B
Asia Growth	8.38%	29.65%	10.24%	2.32%	21.06%
North & South America	68.17B	33.29B	27.54B	22.93B	13.10B
North & South America Growth	104.78%	20.89%	20.11%	75.04%	151.37%
Europe and Middle East	60.53B	58.72B	45.24B	39.87B	21.22B
Europe and Middle East Growth	3.07%	29.79%	13.49%	87.89%	43.86%
Other	18.96B	14.59B	12.68B	4.61B	2.93B
Other Growth	29.92%	15.06%	175.22%	57.31%	14.10%
Discontinued Business (*)	-	-	-	10.34B	-
Total	425.11B	373.05B	319.70B	292.02B	231.86B
Total Growth	13.96%	16.69%	9.48%	25.95%	9.87%

Source: S&P Global Market Intelligence.